Eliane Piaggio
13Patents
3h-index
16Co-inventors
53Inventor score
Filing activity: Mar 29, 2011 → Sep 24, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10293028B2 | Use of low dose IL-2 for treating autoimmune related or inflammatory disorders | Human Necessities | 19 | Active |
| US9669071B2 | Method for stimulating T lymphocytes with IL-2 | Human Necessities | 9 | Active |
| US10765723B2 | Use of low dose IL-2 for treating autoimmune—related or inflammatory disorders | Human Necessities | 4 | Active |
| US10576103B2 | Immune cells defective for SUV39H1 | Chemistry; Metallurgy | 2 | Active |
| US10183061B2 | Boosting Treg cells for treating Alzheimer disease and related disorders | Chemistry; Metallurgy | 1 | Active |
| US12371471B2 | Immune cells defective for SUV39H1 | Chemistry; Metallurgy | 0 | Active |
| US11285176B2 | Immune cells defective for Suv39h1 | Chemistry; Metallurgy | 0 | Active |
| US9457096B2 | Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery | Emerging Cross-Sectional Technologies | 0 | Active |
| US11622978B2 | Immune cells defective for SUV39H1 | Chemistry; Metallurgy | 0 | Active |
| US10114018B2 | IL-2 peptide derivatives, and uses thereof for the diagnosis and treatment of an autoimmune disease | Physics | 0 | Active |
| US9801927B2 | Pharmaceutical compositions comprising a polypeptide comprising at least one CXXC motif and heterologous antigens and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11559566B2 | Use of low dose IL-2 for treating autoimmune-related or inflammatory disorders | Human Necessities | 0 | Active |
| US9757471B2 | Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.